Predictors and Prognosis of Symptomatic Intracranial Hemorrhage in Acute Ischemic Stroke Patients Without Thrombolysis: Analysis of Data From the Chinese Acute Ischemic Stroke Treatment Outcome Registry
- PMID: 34650508
- PMCID: PMC8506002
- DOI: 10.3389/fneur.2021.727304
Predictors and Prognosis of Symptomatic Intracranial Hemorrhage in Acute Ischemic Stroke Patients Without Thrombolysis: Analysis of Data From the Chinese Acute Ischemic Stroke Treatment Outcome Registry
Abstract
Background and Purpose: There is limited information on symptomatic intracranial hemorrhage (sICH) in stroke patients without thrombolysis. This study aimed to evaluate the risk factors of sICH and the association between sICH and the prognosis at 3 and 12 months in acute ischemic stroke patients without thrombolysis. Methods: Data originated from the Chinese Acute Ischemic Stroke Treatment Outcome Registry. Univariate analysis and multivariate logistic regression were used to screen the risk factors of sICH. Multivariable logistic regression models were used to assess the association of sICH with poor outcome and all-cause mortality. Results: Totally, 9,484 patients were included, of which 69 (0.73%) had sICH. Atrial fibrillation (odds ratio [OR], 3.682; 95% confidence interval [CI], 1.945-6.971; p < 0.001), history of tumors (OR, 2.956; 95% CI, 1.115-7.593; p = 0.024), and the National Institutes of Health Stroke Scale (NIHSS) score on admission ([6-15: OR, 2.344; 95% CI, 1.365-4.024; p = 0.002] [>15: OR, 4.731; 95% CI, 1.648-13.583; p = 0.004]) were independently associated with sICH. After adjustment of the confounders, patients with sICH had a higher risk of poor outcome (OR, 1.983; 95% CI, 1.117-3.521; p = 0.018) at 3 months and that of all-cause mortality at 3 (OR, 6.135; 95% CI, 2.328-16.169; p < 0.001) and 12 months (OR, 3.720; 95% CI, 1.513-9.148; p = 0.004). Conclusion: sICH occurred in 0.73% of acute ischemic stroke patients without thrombolysis and was associated with a worse prognosis at 3 and 12 months. Atrial fibrillation, history of tumors, and NIHSS score at admission were independent risk factors of sICH.
Keywords: atrial fibrillation; ischemic stroke; prognosis; risk factors; symptomatic intracranial hemorrhage; tumor.
Copyright © 2021 Shen, Jin, Lu, Sun, Liu, Li, Shu, Tai, Li, Chen, Zhang, Zhang, Sun, Qiu, Wei, Sun and Huang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Similar articles
-
A Nomogram to Predict Symptomatic Intracranial Hemorrhage After Intravenous Thrombolysis in Chinese Patients.Neuropsychiatr Dis Treat. 2021 Jul 6;17:2183-2190. doi: 10.2147/NDT.S320574. eCollection 2021. Neuropsychiatr Dis Treat. 2021. PMID: 34262278 Free PMC article.
-
Prognosis and Predictors of Symptomatic Intracranial Hemorrhage After Endovascular Treatment of Large Vessel Occlusion Stroke.Front Neurol. 2022 Jan 21;12:730940. doi: 10.3389/fneur.2021.730940. eCollection 2021. Front Neurol. 2022. PMID: 35126278 Free PMC article.
-
Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.J Stroke Cerebrovasc Dis. 2014 Jan;23(1):7-11. doi: 10.1016/j.jstrokecerebrovasdis.2012.04.004. Epub 2012 May 11. J Stroke Cerebrovasc Dis. 2014. PMID: 22578915
-
Symptomatic intracranial hemorrhage following intravenous thrombolysis for acute ischemic stroke: a critical review of case definitions.Cerebrovasc Dis. 2012;34(2):106-14. doi: 10.1159/000339675. Epub 2012 Aug 1. Cerebrovasc Dis. 2012. PMID: 22868870 Review.
-
Intravenous thrombolysis for ischemic stroke with hyperdense middle cerebral artery sign: A meta-analysis.Acta Neurol Scand. 2020 Mar;141(3):193-201. doi: 10.1111/ane.13177. Epub 2019 Nov 3. Acta Neurol Scand. 2020. PMID: 31598961 Review.
Cited by
-
Hemorrhagic Coagulation Disorders and Ischemic Stroke: How to Reconcile Both?Neurol Int. 2023 Nov 30;15(4):1443-1458. doi: 10.3390/neurolint15040093. Neurol Int. 2023. PMID: 38132972 Free PMC article. Review.
-
Early Hemorrhagic Transformation after Reperfusion Therapy in Patients with Acute Ischemic Stroke: Analysis of Risk Factors and Predictors.Brain Sci. 2023 May 22;13(5):840. doi: 10.3390/brainsci13050840. Brain Sci. 2023. PMID: 37239312 Free PMC article.
-
Prolonged Hospital Length of Stay Does Not Improve Functional Outcome in Acute Ischemic Stroke.Neurol Ther. 2025 Apr;14(2):593-607. doi: 10.1007/s40120-025-00712-2. Epub 2025 Feb 18. Neurol Ther. 2025. PMID: 39964661 Free PMC article.
-
Thrombolysis in central retinal artery occlusion: a retrospective observational study.J Neurol. 2023 Feb;270(2):891-897. doi: 10.1007/s00415-022-11439-7. Epub 2022 Oct 28. J Neurol. 2023. PMID: 36305969 Free PMC article.
-
Integrating Neutrophil-To-Albumin Ratio and Triglycerides: A Novel Indicator for Predicting Spontaneous Hemorrhagic Transformation in Acute Ischemic Stroke Patients.CNS Neurosci Ther. 2024 Dec;30(12):e70133. doi: 10.1111/cns.70133. CNS Neurosci Ther. 2024. PMID: 39690502 Free PMC article.
References
-
- Vos T, Lim SS, Abbafati C, Abbas KM, Abbasi M, Abbasifard M, et al. . Global burden of 369 diseases and injuries in 204 countries and territories, 1990–2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. (2020) 396:1204–22. 10.1016/S0140-6736(20)30925-9 - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources